KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1
Metrics: PDF 1306 views | HTML 1424 views | ?
Mei-Ting Qiu1,*, Qiong Fan1,*, Zhu Zhu2,*, Suet-Ying Kwan2, Limo Chen3, Jin-Hong Chen4, Zuo-Lin Ying5, Ye Zhou1, Wei Gu1, Li-Hua Wang1, Wei-Wei Cheng1, Jianfang Zeng6, Xiao-Ping Wan4, Samuel C. Mok2, Kwong-Kwok Wong2, Wei Bao1,2
1Departments of Obstetrics and Gynecology, International Peace Maternity & Child Health Hospital affiliated with the Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
3Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
4Departments of Obstetrics and Gynecology, Shanghai First Maternity and Infant Hospital, TongJi University School of Medicine, Shanghai, China
5Department of Dermatology, Shanghai First People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
6Department of Laboratory Medicine and the Center for Stem Cell and Developmental Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
*These authors have contributed equally to this work
Wei Bao, e-mail: firstname.lastname@example.org
Keywords: endometrial cancer, lysine demethylases KDM4B and KDM4A, androgen receptor, histone modification, c-myc, p27kip1, prognosis
Received: May 21, 2015 Accepted: August 29, 2015 Published: September 11, 2015
Epidemiological evidence suggests that elevated androgen levels and genetic variation related to the androgen receptor (AR) increase the risk of endometrial cancer (EC). However, the role of AR in EC is poorly understood. We report that two members of the histone demethylase KDM4 family act as major regulators of AR transcriptional activityin EC. In the MFE-296 cell line, KDM4B and AR upregulate c-myc expression, while in AN3CA cells KDM4A and AR downregulate p27kip1. Additionally, KDM4B expression is positively correlated with AR expression in EC cell lines with high baseline AR expression, while KDM4A and AR expression are positively correlated in low-AR cell lines. In clinical specimens, both KDM4B and KDM4A expression are significantly higher in EC tissues than that in normal endometrium. Finally, patients with alterations in AR, KDM4B, KDM4A, and c-myc have poor overall and disease-free survival rates. Together, these findings demonstrate that KDM4B and KDM4A promote EC progression by regulating AR activity.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.